
Reset all filters
01 4Alkermes Plc
Reset all filters
01 4TABLET;ORAL
Reset all filters
01 4RX
Reset all filters
01 4LYBALVI
Reset all filters
01 4USA
Regulatory Info : RX
Registration Country : USA
OLANZAPINE; SAMIDORPHAN L-MALATE
Brand Name : LYBALVI
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG;EQ 10MG BASE
Packaging :
Approval Date : 2021-05-28
Application Number : 213378
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
OLANZAPINE; SAMIDORPHAN L-MALATE
Brand Name : LYBALVI
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;EQ 10MG BASE
Packaging :
Approval Date : 2021-05-28
Application Number : 213378
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
OLANZAPINE; SAMIDORPHAN L-MALATE
Brand Name : LYBALVI
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG;EQ 10MG BASE
Packaging :
Approval Date : 2021-05-28
Application Number : 213378
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
OLANZAPINE; SAMIDORPHAN L-MALATE
Brand Name : LYBALVI
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG;EQ 10MG BASE
Packaging :
Approval Date : 2021-05-28
Application Number : 213378
Regulatory Info : RX
Registration Country : USA